Animal model of dementia induced by entorhinal synaptic damage and partial restoration of cognitive deficits by BDNF and carnitine

被引:91
作者
Ando, S
Kobayashi, S
Waki, H
Kon, K
Fukui, F
Tadenuma, T
Iwamoto, M
Takeda, Y
Izumiyama, N
Watanabe, K
Nakamura, H
机构
[1] Tokyo Metropolitan Inst Gerontol, Neuronal Funct Res Grp, Itabashi Ku, Tokyo 1730015, Japan
[2] Tokyo Metropolitan Inst Gerontol, Div Neurosci, Cell Recognit Res Grp, Itabashi Ku, Tokyo 1730015, Japan
[3] Tokyo Metropolitan Inst Gerontol, Div Physiol & Aging, Ageing Organ & Tissue Res Grp, Tokyo 1730015, Japan
[4] Nagaoka Univ Technol, Dept Bioengn, Nagaoka, Niigata 94021, Japan
[5] Saitama Med Sch, Dept Anat, Moroyama, Saitama, Japan
关键词
dementia model; entorhinal cortex; botulinum toxin; learning; memory; BDNF; carnitine; synaptic plasticity;
D O I
10.1002/jnr.10443
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
A rat dementia model with cognitive deficits was generated by synapse-specific lesions using botulinum neurotoxin (BoNTx) type B in the entorhinal cortex. To detect cognitive deficits, different tasks were needed depending upon the age of the model animals. Impaired learning and memory with lesions were observed in adult rats using the Hebb-Williams maze, AKON-1 maze and a continuous alternation task in T-maze. Cognitive deficits in lesioned aged rats were detected by a continuous alternation and delayed non-matching-to-sample tasks in T-maze. Adenovirus-mediated BDNF gene expression enhanced neuronal plasticity, as revealed by behavioral tests and LTP formation. Chronic administration of carnitine over time pre- and post-lesions seemed to partially ameliorate the cognitive deficits caused by the synaptic lesion. The carnitine-accelerated recovery from synaptic damage was observed by electron microscopy. These results demonstrate that the BoNTx-lesioned rat can be used as a model for dementia and that cognitive deficits can be alleviated in part by BDNF gene transfer or carnitine administration. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:519 / 527
页数:9
相关论文
共 73 条
[51]   Regular review -: Uses of botulinum toxin injection in medicine today [J].
Münchau, A ;
Bhatia, KP .
BRITISH MEDICAL JOURNAL, 2000, 320 (7228) :161-165
[52]   Activity-dependent formation of perforated synapses in cultured hippocampal neurons [J].
Neuhoff, H ;
Roeper, J ;
Schweizer, M .
EUROPEAN JOURNAL OF NEUROSCIENCE, 1999, 11 (12) :4241-4250
[53]   BETA-AMYLOID PROTEIN-INDUCED ALZHEIMERS-DISEASE ANIMAL-MODEL [J].
NITTA, A ;
ITOH, A ;
HASEGAWA, T ;
NABESHIMA, T .
NEUROSCIENCE LETTERS, 1994, 170 (01) :63-66
[54]   CLINICAL AND NEUROCHEMICAL EFFECTS OF ACETYL-L-CARNITINE IN ALZHEIMERS-DISEASE [J].
PETTEGREW, JW ;
KLUNK, WE ;
PANCHALINGAM, K ;
KANFER, JN ;
MCCLURE, RJ .
NEUROBIOLOGY OF AGING, 1995, 16 (01) :1-4
[55]   Genetic neurodegenerative diseases: The human illness and transgenic models [J].
Price, DL ;
Sisodia, SS ;
Borchelt, DR .
SCIENCE, 1998, 282 (5391) :1079-1083
[56]   Neuron number in the entorhinal cortex and CA1 in preclinical Alzheimer disease [J].
Price, JL ;
Ko, AI ;
Wade, MJ ;
Tsou, SK ;
McKeel, DW ;
Morris, JC .
ARCHIVES OF NEUROLOGY, 2001, 58 (09) :1395-1402
[57]   Cholinergic immunolesions by 192IGG-saporin - A useful tool to simulate pathogenic aspects of Alzheimer's disease [J].
Rossner, S .
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE, 1997, 15 (07) :835-850
[58]  
SATHYAMOORTHY V, 1985, J BIOL CHEM, V260, P461
[59]   SYNAPSE LOSS IN THE TEMPORAL-LOBE IN ALZHEIMERS-DISEASE [J].
SCHEFF, SW ;
PRICE, DA .
ANNALS OF NEUROLOGY, 1993, 33 (02) :190-199
[60]   QUANTITATIVE ASSESSMENT OF SYNAPTIC DENSITY IN THE ENTORHINAL CORTEX IN ALZHEIMERS-DISEASE [J].
SCHEFF, SW ;
SPARKS, L ;
PRICE, DA .
ANNALS OF NEUROLOGY, 1993, 34 (03) :356-361